Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Vaginal drug delivery

FIGURE 22.1 Number of scientific papers and patents published on the topic as a function of publication year (2005 until June). (From SciFinder Scholar, 2004 keywords entered vaginal drug delivery systems.)... [Pg.442]

Human vagina is an S-shaped fibromuscular collapsible tube, 6-10 cm long, extending from cervix to uterus and located between the bladder and the rectum [1], It presents unique features in terms of secretions (pH and composition) and microflora, which must be considered during the development and the evaluation of vaginal drug delivery systems [2],... [Pg.443]

The bioadhesive properties of hydrophobic polybasic gels containing ACV-dimethylami-noethyl methacrylate-co-methyl methacrylate were investigated in view of their use as vaginal drug delivery systems [72]. The bioadhesive properties of such gels make them suitable for site-specific and pH-controlled drug delivery. [Pg.454]

Vermani, K., and S. Garg. 2000. The scope and potential of vaginal drug delivery. PTTS 10 359. [Pg.466]

Hwang, S., et al. 1977. System approach to vaginal drug delivery of drugs. II. In situ absorption of unbranched aliphatic alcohols. J Pharm Sci 65 1574. [Pg.466]

Kast, E.K., et al. 2002. Design and in vitro evaluation of a novel bioadhesive vaginal drug delivery... [Pg.468]

Pavelic, Z., N.S. Skalko-Basnet, and R. Schubert. 2001. Liposomal gels for vaginal drug delivery. Int J Pharm 219 139. [Pg.469]

Hsu, C.C., et al. 1984. Topical vaginal drug delivery. I. Effects of the oestrous cycle on vaginal membrane permeability and diffusivity of vidabirine in mice. J Pharm Sci 72 674. [Pg.470]

Physiological factors affecting vaginal drug delivery... [Pg.273]

PHYSIOLOGICAL FACTORS AFFECTING VAGINAL DRUG DELIVERY... [Pg.276]

Drug properties which affect vaginal drug delivery are broadly the same as those affecting transepithelial absorption at any site and have been discussed extensively in Chapter 1 (Section 1.3.4). [Pg.282]

These factors become particularly important for preparations intended for long-term vaginal administration. Formulation factors which affect vaginal drug delivery which are common to the various types of vaginal dosage forms include ... [Pg.283]

New technologies in vaginal drug delivery which are demonstrating considerable potential include ... [Pg.289]

Other Strategies and Vaginal Drug Delivery Systems... [Pg.809]

Clinical Usage and Potential of Vaginal Drug Delivery... [Pg.810]

See other pages where Vaginal drug delivery is mentioned: [Pg.396]    [Pg.405]    [Pg.412]    [Pg.444]    [Pg.447]    [Pg.454]    [Pg.65]    [Pg.66]    [Pg.62]    [Pg.67]    [Pg.273]    [Pg.273]    [Pg.273]    [Pg.275]    [Pg.285]    [Pg.286]    [Pg.289]    [Pg.439]    [Pg.809]    [Pg.809]    [Pg.809]    [Pg.809]    [Pg.810]    [Pg.810]    [Pg.811]    [Pg.812]    [Pg.813]    [Pg.814]    [Pg.816]   
See also in sourсe #XX -- [ Pg.9 , Pg.50 ]

See also in sourсe #XX -- [ Pg.28 ]



SEARCH



Vaginal

Vaginal and uterine drug delivery

Vaginal drug delivery bioadhesive

Vaginal drug delivery developments

Vaginal drug delivery liposomes

Vaginal drug delivery poly

Vaginal drug delivery types

Vaginitis

© 2024 chempedia.info